Abstract
Background
The cellular repressor of E1A-stimulated genes (CREG), a secreted glycoprotein, has been studied with human embryonic carcinoma cells, vascular smooth muscle cells, and NIH3T3 fibroblasts. However, its relationship to tumor cell proliferation and metastasis has not been examined in human gastric cancers (GC) until now.
Aim
To investigate the expression of CREG in GC and its association with GC cell proliferation and metastasis.
Methods
Forty-two cases of GCs, matched normal gastric tissues, and the human gastric cancer cell lines BGC-823, SGC-7901, MKN45, normal gastric mucosa cell line GES, and HUVEC cell line ECV304 were used to analyze CREG expression at the level of mRNA and protein. The expression of CREG was then further examined by immunohistochemistry in 42 GC tissues, and the correlation between the level of CREG and the pathological and clinical data was evaluated. Finally, we down-regulated the expression of CREG in GC cells with specific siRNA, and assessed the role of CREG in the proliferation and metastasis/invasion of the GC cell line.
Results
The level of CREG was found to be higher in malignant GC tissues and cells compared to adjacent normal tissues and normal gastric cells (p < 0.001). Additionally, the expression levels of CREG were positively correlated with tumor clinical stage (p = 0.001), tumor metastasis (p < 0.001), and stages of tumor infiltration (p = 0.019). Furthermore, by using siRNA, we found that the down-regulated expression of CREG inhibited the proliferation of GC cells (p < 0.05), and migration of both GC cells (p = 0.001).
Conclusions
Our data suggest that CREG plays an important role in gastric cancer cell proliferation and metastasis and that CREG may be a potential therapeutic target for GC.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Catalano V, Labianca R, Beretta GD, et al. Gastric cancer. Crit Rev Oncol Hematol. 2009;71:127–164.
Dicken BJ, Bigam DL, Cass C, et al. Gastric adenocarcinoma: Review and considerations for future directions. Ann Surg. 2005;241:27–39.
Sacher M, Di Bacco A, Lunin VV, et al. The crystal structure of CREG, a secreted glycoprotein involved in cellular growth and differentiation. Proc Natl Acad Sci U S A. 2005;102:18326–18331.
Han Y, Wu G, Deng J, et al. Cellular repressor of E1A-stimulated genes inhibits human vascular smooth muscle cell apoptosis via blocking P38/JNK MAP kinase activation. J Mol Cell Cardiol. 2010;48:1225–1235.
Veal E, Groisman R, Eisenstein M, et al. The secreted glycoprotein CREG enhances differentiation of NTERA-2 human embryonal carcinoma cells. Oncogene. 2000;19:2120–2128.
Liu WX, Hao XS. Screening, cloning and identification of the human endometrial carcinoma-related genes. Zhonghua Zhong Liu Za Zhi. 2007;29:584–588.
Birkenkamp-Demtroder K, Olesen SH, Sørensen FB, et al. Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid. Gut. 2005;54:374–384.
Sicinschi LA, Correa P, Peek RM, et al. CagA C- terminal variations in Helicobacter pylori strains from Colombian patients with gastric precancerous lesions. Clin Microbiol Infect. 2010;16:369–378.
Chen SM, Jiang CY, Wu JY, et al. RNA interference-mediated silencing of UBCH10 gene inhibits colorectal cancer cell growth in vitro and in vivo. Clin Exp Pharmacol Physiol. 2010;37:525–529.
Moore LD, Isayeva T, Siegal GP, et al. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer. Implications for proliferation and migration in vitro and metastasis in vivo. Clin Cancer Res. 2008;14:4961–4970.
Pilquil C, Dewald J, Cherney A, et al. Lipid phosphate phosphatase-1 regulates lysophosphatidate-induced fibroblast migration by controlling phospholipase D2-dependent phosphatidate generation. J Biol Chem. 2006;281:38418–38429.
Ma J, Sawai H, Ochi N, et al. PTEN regulate angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells. Mol Cell Biochem. 2009;331:161–171.
Schähsa P, Weidingera P, Probsta OC, et al. Cellular repressor of E1A-stimulated genes is a bona fide lysosomal protein which undergoes proteolytic maturation during its biosynthesis. Genes cells. 2008;13:977–986.
Han Y, Deng J, Guo L, et al. CREG promotes a mature smooth muscle cell phenotype and reduces neointimal formation in balloon-injured rat carotid artery. Cardiovasc Res. 2008;78:597–604.
Veal E, Eisenstein M, Tseng ZH, et al. A cellular repressor of E1A-stimulated genes that inhibits activation by E2F. Mol Cell Biol. 1998;18:5032–5041.
Han YL, Guo P, Sun MY, et al. Secreted CREG inhibits cell proliferation mediated by mannose 6-phosphate/insulin-like growth factor II receptor in NIH3T3 fibroblasts. Genes Cells. 2008;13:977–986.
Gordon PV, Paxton JB, Fox NS. The cellular repressor of E1A-stimulated genes mediates glucocorticoid-induced loss of the type-2 IGF receptor in ileal epithelial cells. J Endocrinol. 2005;185:265–273.
Yoo CH, Noh SH, Shin DW, et al. Recurrence following curative resection for gastric carcinoma. Br J Surg. 2000;87:236–242.
Ruiter DJ, van Krieken JH, van Muijen GN, et al. Tumour metastasis: Is tissue an issue? Lancet Oncol. 2001;2:109–112.
Acknowledgments
This research was supported in part by grants from Biomedical Project Science Technology Committee of Shanghai (08411963000). The authors thank Miss Yong Hua for excellent advice and critical reading of this paper and Miss Natchar Ratanasirigulchai for proofreading of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Xu, L., Wang, F., Liu, H. et al. Increased Expression of Cellular Repressor of E1A-Stimulated Gene (CREG) in Gastric Cancer Patients: A Mechanism of Proliferation and Metastasis in Cancer. Dig Dis Sci 56, 1645–1655 (2011). https://doi.org/10.1007/s10620-010-1510-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-010-1510-0